Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287–99.

Article  PubMed  PubMed Central  Google Scholar 

Gangane NM, Patil BU, Ghongade PV. Ovarian cancer: A report from population-based cancer registry at central rural India. J Cancer Res Ther. 2023;19(Suppl 2):S857–62.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA: A Cancer J Clin. 2022;72(1):7–33.

Google Scholar 

Ebell MH, Culp MB, Radke TJ. A systematic review of symptoms for the diagnosis of ovarian cancer. Am J Prev Med. 2016;50(3):384–94.

Article  PubMed  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2018;68(6):394–424.

Google Scholar 

Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3–14.

Article  PubMed  Google Scholar 

Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387(10022):945–56.

Article  PubMed  PubMed Central  Google Scholar 

Babadi AJ, Kouti RN, Zeinali M, Lordejani MA, Marandi HJ, Farhadi E. Effect of cervical index changes on cervical pain. J Iranian Med Council. 2024.

Oncul S, Cho MS. Interactions between platelets and tumor microenvironment components in ovarian cancer and their implications for treatment and clinical outcomes. Cancers. 2023;15(4).

Eggemann H, Ehricke J, Ignatov T, Fettke F, Semczuk A, Costa SD, et al. Platelet count after chemotherapy is a predictor for outcome for ovarian cancer patients. Cancer Invest. 2015;33(5):193–6.

Article  PubMed  CAS  Google Scholar 

Lin RJ, Afshar-Kharghan V, Schafer AI. Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood. 2014;124(2):184–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kazemi N, Bordbar A, Bavarsad SS, Ghasemi P, Bakhshi M, Rezaeeyan H. Molecular insights into the relationship between platelet activation and endothelial dysfunction: molecular approaches and clinical practice. Mol Biotechnol. 2024;66(5):932–47.

Article  PubMed  CAS  Google Scholar 

Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009;19(2):156–72.

Article  PubMed  CAS  Google Scholar 

Gao J, Zhu Y, Nilsson M, Sundfeldt K. TGF-β isoforms induce EMT independent migration of ovarian cancer cells. Cancer Cell Int. 2014;14(1):72.

Article  PubMed  PubMed Central  Google Scholar 

Pluta K, Porębska K, Urbanowicz T, Gąsecka A, Olasińska-Wiśniewska A, Targoński R, et al. Platelet-Leucocyte aggregates as novel biomarkers in cardiovascular diseases. Biology. 2022;11(2):224.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schon HT, Weiskirchen R. Immunomodulatory effects of transforming growth factor-β in the liver. Hepatobiliary Surg Nutr. 2014;3(6):386–406.

PubMed  PubMed Central  Google Scholar 

Roane BM, Arend RC, Birrer MJ. Review: targeting the transforming growth factor-beta pathway in ovarian cancer. Cancers. 2019;11(5).

Karolczak K, Watala C. Blood platelets as an important but underrated circulating source of TGFβ. Int J Mol Sci. 2021;22(9):4492.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stark K. Platelet-neutrophil crosstalk and netosis. Hemasphere. 2019;3(Suppl):89.

Article  PubMed  PubMed Central  Google Scholar 

Demkow U. Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis. Cancers. 2021;13(17):4495.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tomás-Pérez S, Oto J, Aghababyan C, Herranz R, Cuadros-Lozano A, González-Cantó E, et al. Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients’ biofluids: potential role in disease diagnosis and management. Front Immunol. 2023;14.

Castaño M, Tomás-Pérez S, González-Cantó E, Aghababyan C, Mascarós-Martínez A, Santonja N, et al. Neutrophil extracellular traps and cancer: trapping our attention with their involvement in ovarian cancer. Int J Mol Sci. 2023;24(6):5995.

Article  PubMed  PubMed Central  Google Scholar 

Waters JA, Robinson M, Lujano-Olazaba O, Lucht C, Gilbert SF, House CD. Omental preadipocytes stimulate matrix remodeling and IGF signaling to support ovarian cancer metastasis. Cancer Res. 2024;84(13):2073–89.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang Y, Yang Y, Yang J, Zhao X, Wei X. Tumor microenvironment in ovarian cancer: function and therapeutic strategy. Front Cell Dev Biol. 2020;8:758.

Article  PubMed  PubMed Central  Google Scholar 

Garlisi B, Lauks S, Aitken C, Ogilvie LM, Lockington C, Petrik D, et al. The complex tumor microenvironment in ovarian cancer: therapeutic challenges and opportunities. Curr Oncol. 2024;31(7):3826–44.

Article  PubMed  PubMed Central  Google Scholar 

Blanc-Durand F, Clemence Wei Xian L, Tan DSP. Targeting the immune microenvironment for ovarian cancer therapy. Front Immunol. 2023;14:1328651.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Savant SS, Sriramkumar S, O’Hagan HM. The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer. Cancers. 2018;10(8):251.

Article  PubMed  PubMed Central  Google Scholar 

Worzfeld T, Pogge von Strandmann E, Huber M, Adhikary T, Wagner U, Reinartz S, et al. The unique molecular and cellular microenvironment of ovarian cancer. Front Oncol. 2017;7:24.

Article  PubMed  PubMed Central  Google Scholar 

Ahmadipour E, Lakkakula BV, Vahdani G, Tolouian R, Haghi HR, Delgado D, et al. Understanding kidney injury in COVID-19; a pressing priority. J Nephropharmacol. 2020;10(2):e19-e.

Article  Google Scholar 

Zhang M, Chen Z, Wang Y, Zhao H, Du Y. The role of cancer-associated fibroblasts in ovarian cancer. Cancers. 2022;14(11):2637.

Article  PubMed  PubMed Central  Google Scholar 

Yang Y, Yang Y, Yang J, Zhao X, Wei X. Tumor microenvironment in ovarian cancer: function and therapeutic strategy. Front Cell Developmen Biol. 2020;8.

Luo X, Xu J, Yu J, Yi P. Shaping immune responses in the tumor microenvironment of ovarian cancer. Front Immunol. 2021;12.

Wang AW, Prieto JM, Cauvi DM, Bickler SW, De Maio A. The Greater Omentum-A vibrant and enigmatic immunologic organ involved in injury and infection resolution. Shock. 2020;53(4):384–90.

Article  PubMed  PubMed Central  Google Scholar 

Güç E, Pollard JW. Redefining macrophage and neutrophil biology in the metastatic cascade. Immunity. 2021;54(5):885–902.

Article  PubMed  Google Scholar 

Khayat Kashani HR, Alizadeh P, Salimi S, Habtemariam S, Khayatkashani M, Tewari D. Epidemiologic profile and outcome of primary pediatric brain tumors in Iran: retrospective study and literature review. Child's Nervous Syst. 2022:1–8.

Schweer D, Anderson A, Anand N, McCorkle JR, Neupane K, Hill K, et al. Human macrophage-engineered vesicles for utilization in ovarian cancer treatment (179). Gynecol Oncol. 2023;176:S70.

Article  Google Scholar 

Colvin EK. Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol. 2014;4.

Locatelli L, Colciago A, Castiglioni S, Maier JA. Platelets in wound healing: what happens in space? Front Bioeng Biotechnol. 2021;9.

Ali RA, Wuescher LM, Worth RG. Platelets: essential components of the immune system. Curr Trends Immunol. 2015;16:65–78.

PubMed  PubMed Central  Google Scholar 

Farhid F, Hosseini E, Kargar F, Ghasemzadeh M. Interplay between platelet and T lymphocyte after coronary artery bypass grafting (CABG): evidence for platelet mediated post-CABG immunomodulation. Microvasc Res. 2025;160: 104805.

Article  PubMed  CAS  Google Scholar 

Braun A, Anders H-J, Gudermann T, Mammadova-Bach E. Platelet-cancer interplay: molecular mechanisms and new therapeutic avenues. Front Oncol. 2021;11.